**Core Concept**
The question is testing the understanding of the role of interleukins in bone resorption, specifically the most potent interleukin involved in this process. Interleukins are a group of cytokines that play a crucial role in the immune response, and some of them are involved in the regulation of bone metabolism.

**Why the Correct Answer is Right**
The correct answer is RANKL (Receptor Activator of Nuclear factor Kappa-Β Ligand), which is a potent bone-resorbing interleukin. RANKL is a protein that binds to its receptor, RANK, on osteoclasts, leading to the activation of osteoclasts and subsequent bone resorption. This process is essential for bone remodeling and calcium homeostasis. RANKL is produced by osteoblasts, T cells, and other cell types, and its expression is regulated by various cytokines, including interleukins.

**Why Each Wrong Option is Incorrect**
* **Option A:** IL-1β is a pro-inflammatory cytokine that can stimulate bone resorption, but it is not the most potent interleukin involved in this process.
* **Option B:** TNF-α is a cytokine that can stimulate bone resorption, but it is not as potent as RANKL in this regard.
* **Option C:** IL-6 is a cytokine that can stimulate bone resorption, but it is not the most potent interleukin involved in this process.

**Clinical Pearl / High-Yield Fact**
RANKL inhibitors are a class of drugs that are used to treat osteoporosis and other bone-related disorders. These drugs work by inhibiting the activity of RANKL, leading to a decrease in bone resorption and an increase in bone density.

**Correct Answer:** C. RANKL (Receptor Activator of Nuclear factor Kappa-Β Ligand)